Replies to post #25985 on Ariad Pharmaceuticals Inc fka ARIA

[glass_half_full]

Underwriter's have 30 days to purchase remaining over allotments.

Good point.

With the exception of #5 aren't these overdue?

Actually, IMHO, I would say that it is #5 that is really overdue.

The Q4 call will be their first chance to give give color on #1, and 2-4 are sort of updates to earlier reports, so I'd think that the call would be the expected time.

As for new molecules, it'll be 4 years in April....

[biotech_researcher]

Someone might want to tell Dew that Underwriter's have 30 days to purchase remaining over allotments. He made a mildly bearish comment on Ariad over at the Biotech Value board.